Segment Reporting – Information by division

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Merck Serono3

Consumer Health3

Performance Materials

Merck Millipore

Corporate and Other

Merck Group

€ million

Q1 – 2014

Q1 – 2013

Q1 – 2014

Q1 – 2013

Q1 – 2014

Q1 – 2013

Q1 – 2014

Q1 – 2013

Q1 – 2014

Q1 – 2013

Q1 – 2014

Q1 – 2013

1

Reporting period ending on March 31, 2014. Previous year’s figures as of December 31, 2013.

2

According to the consolidated cash flow statement.

3

Previous year’s figures have been adjusted, see following explanations.

Sales

1,374.9

1,388.8

180.2

181.7

402.2

421.3

656.5

668.7

2,613.9

2,660.4

Royalty, license and commission income

46.2

93.3

0.3

0.1

0.5

0.8

3.9

5.8

51.0

100.1

Total revenues

1,421.1

1,482.1

180.5

181.8

402.7

422.1

660.4

674.5

2,664.8

2,760.5

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross profit

1,166.8

1,251.9

120.9

124.9

246.0

265.8

395.7

394.9

–1.1

–1.0

1,928.3

2,036.5

Marketing and selling expenses

–279.8

–294.8

–68.1

–69.1

–32.6

–35.5

–168.6

–169.5

–0.5

0.6

–549.5

–568.3

Royalty, license and commission expenses

–131.7

–131.5

0.3

–0.7

–0.7

–0.4

–4.1

–3.7

–136.4

–136.3

Administration expenses

–52.2

–50.2

–6.3

–5.8

–7.7

–7.0

–28.6

–26.8

–37.5

–42.9

–132.3

–132.7

Other operating expenses and income

–26.3

–127.7

–4.6

–6.2

–12.6

–10.5

–19.8

–30.8

–3.4

–8.8

–66.8

–184.0

Research and development costs

–298.3

–322.5

–4.8

–5.7

–37.0

–36.4

–38.4

–41.3

–0.4

–0.3

–378.9

–406.2

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating result (EBIT)

235.8

170.2

36.7

36.8

151.7

172.5

87.0

72.3

–42.9

–52.4

468.3

399.4

Depreciation and amortization

190.9

209.8

2.4

2.8

27.2

30.7

76.6

79.1

3.5

3.6

300.6

325.9

Impairment losses

1.3

28.3

0.1

0.1

0.1

0.1

1.4

28.6

Reversals of impairment losses

–0.1

–0.1

–0.1

–0.1

EBITDA

428.0

408.3

39.1

39.4

178.8

203.3

163.7

151.5

–39.4

–48.7

770.2

753.8

One-time items

10.1

29.4

2.2

–0.1

7.6

4.1

5.9

10.4

11.1

3.4

36.8

47.3

EBITDA pre one-time items (Segment result)

438.0

437.7

41.3

39.3

186.4

207.4

169.7

161.9

–28.3

–45.3

807.1

801.1

 

 

 

 

 

 

 

 

 

 

 

 

 

EBITDA margin pre one-time items (% of sales)

31.9

31.5

22.9

21.6

46.3

49.2

25.8

24.2

30.9

30.1

 

 

 

 

 

 

 

 

 

 

 

 

 

Net operating assets1

6,670.8

6,890.7

346.1

335.5

1,034.3

1,044.7

6,017.1

5,987.1

77.3

36.0

14,145.5

14,294.0

Segment liabilities1

–1,368.9

–1,358.0

–96.0

–74.5

–160.4

–155.9

–425.3

–391.9

–48.9

–64.8

–2,099.5

–2,045.1

Investments in property, plant and equipment2

24.8

17.1

1.7

0.6

11.3

9.2

18.6

9.3

1.0

1.3

57.4

37.5

Investments in intangible assets2

2.3

25.0

1.5

0.7

0.8

1.3

1.3

2.1

1.8

7.9

28.9

 

 

 

 

 

 

 

 

 

 

 

 

 

Net cash flows from operating activities2

446.3

332.8

30.9

22.4

167.9

203.7

99.7

106.9

–336.0

–150.0

408.7

515.7

Business free cash flow

480.0

340.0

16.2

20.8

165.5

199.0

54.4

81.1

–31.9

–48.1

684.1

592.9